SPAC11D3.07c Antibody

What is SPAC11D3.07c and why are antibodies against it important for fission yeast research?

SPAC11D3.07c is a gene locus in Schizosaccharomyces pombe (fission yeast) encoding a protein whose function can be studied using specific antibodies. Antibodies against this target are crucial for understanding protein expression, localization, and interactions within cellular contexts. These antibodies enable researchers to track protein dynamics in various physiological conditions, particularly in studying cellular processes unique to this model organism .

Unlike commercial questions about product availability, the scientific significance lies in how these antibodies facilitate mechanistic studies of conserved eukaryotic pathways that can be extrapolated to higher organisms, including humans.

What applications are optimal for SPAC11D3.07c antibody use in fission yeast research?

The primary applications for SPAC11D3.07c antibody include:

• Western Blot (WB): For detecting protein expression levels and molecular weight confirmation

• ELISA (EIA): For quantitative analysis of protein concentration in samples

• Immunohistochemistry (IHC): For localization studies in fixed tissues

The antibody has been validated for these applications with specific protocols optimized for S. pombe research . For Western blotting, researchers should use reducing conditions similar to those applied for other S. pombe proteins, while ensuring proper sample preparation to maintain the native structure of the target protein.

How does sample preparation affect the detection of SPAC11D3.07c protein?

Sample preparation critically affects antibody performance when detecting SPAC11D3.07c protein. Based on methodologies used for similar S. pombe proteins:

• Cell lysis conditions should preserve protein structure while ensuring sufficient extraction

• Fixation methods (for microscopy) impact epitope accessibility

• Membrane permeabilization techniques affect antibody binding significantly

For optimal results, protocols should include:

• Fresh sample preparation with protease inhibitors

• Standardized protein quantification methods

• Proper denaturation conditions for Western blotting

• Optimized fixation parameters for immunofluorescence

Research with similar fission yeast antibodies demonstrates that both fixation-only and fixation with membrane permeabilization protocols produce distinct results, as documented in studies of other S. pombe proteins .

What are the optimal conditions for using SPAC11D3.07c antibody in Western blotting?

Based on research with similar S. pombe antibodies, the optimal Western blotting conditions include:

• Protein extraction: Use of glass bead lysis in buffer containing protease inhibitors

• Sample preparation: Denaturing conditions with SDS and reducing agent

• Gel selection: 10-12% polyacrylamide gels for optimal resolution

• Transfer conditions: PVDF membrane (0.45 μm) with methanol-containing buffer

• Blocking: 5% non-fat dry milk in TBST or BSA-based blocking solutions

• Antibody dilution: Optimal at 1:1000 to 1:2000 for primary antibody

• Detection: HRP-conjugated secondary antibody followed by ECL detection

For the SPAC11D3.07c antibody specifically, researchers should note that the optimal antibody dilution may need to be determined empirically for each lot, with initial testing of a dilution series .

What controls are essential when using SPAC11D3.07c antibody for immunolocalization studies?

When conducting immunolocalization studies with SPAC11D3.07c antibody, include these essential controls:

• Negative genetic control: SPAC11D3.07c deletion strain

• Positive control: Tagged/overexpressed SPAC11D3.07c

• Secondary antibody-only control: To assess background staining

• Peptide competition: Pre-incubation with immunizing peptide

• Cross-validation: Comparison with GFP-tagged version

• Subcellular markers: Co-staining with known compartment markers

For membrane proteins in S. pombe, both permeabilized and non-permeabilized conditions should be tested to distinguish between surface and intracellular localization, as demonstrated in studies using anti-N-mAb antibodies .

How can SPAC11D3.07c antibody be used to study protein-protein interactions in S. pombe?

For studying protein-protein interactions involving SPAC11D3.07c, the antibody can be applied in multiple advanced protocols:

• Co-immunoprecipitation (Co-IP): Using the antibody to pull down SPAC11D3.07c and associated proteins

• Proximity ligation assay (PLA): For detecting protein interactions in situ

• Chromatin immunoprecipitation (ChIP): If the protein has DNA-binding properties

• STED/STORM microscopy: For super-resolution co-localization studies

• Bimolecular fluorescence complementation: As complementary approach

The Co-IP protocol should be optimized for S. pombe proteins by:

• Using gentle lysis conditions to preserve protein complexes

• Cross-validation with tagged protein versions

• Mass spectrometry analysis of co-precipitated proteins

Research with other S. pombe proteins suggests that appropriate buffer conditions and crosslinking methods significantly impact detection of transient interactions .

What methodological approaches can improve SPAC11D3.07c antibody performance in challenging applications?

For improving antibody performance in challenging applications, implement these methodological refinements:

• Epitope retrieval optimization: For fixed samples, test multiple antigen retrieval methods

• Signal amplification: Use tyramide signal amplification or quantum dots for low-abundance proteins

• Monovalent Fab fragments: For reducing background in specific applications

• Recombinant antibody engineering: Consider single-chain variable fragments for better penetration

• Microfluidic immunocapture: For single-cell analysis applications

For particularly challenging S. pombe samples, researchers have successfully employed:

• Optimized fixation with combined formaldehyde/glutaraldehyde

• Sequential extraction protocols to improve accessibility

• Variable detergent concentrations to balance membrane disruption and epitope preservation

These approaches have been validated in studies of other challenging yeast proteins, resulting in significantly improved signal-to-noise ratios .

How can computational approaches enhance experimental design when using SPAC11D3.07c antibody?

Computational approaches can significantly enhance experimental design with SPAC11D3.07c antibody:

• Epitope prediction: Use algorithms to identify immunogenic regions for validation

• Structural modeling: Employ Alphafold2 for predicting protein structure and accessibility

• Cross-reactivity analysis: Bioinformatic assessment of potential cross-reactive proteins

• Molecular docking simulations: Predict antibody-antigen interactions

• Machine learning optimization: For interpreting complex immunostaining patterns

Implementing computational protocols like IsAb can help:

• Predict optimal binding conditions

• Identify potentially problematic regions

• Guide the design of blocking peptides

• Optimize antibody concentration and incubation conditions

Computational approaches have successfully guided antibody-based studies, as demonstrated in recent work using Alphafold2 and molecular docking to predict antigenic epitopes for antibody binding .

How should researchers interpret multiple bands in Western blots using SPAC11D3.07c antibody?

When encountering multiple bands in Western blots with SPAC11D3.07c antibody, apply this systematic interpretation framework:

• Expected molecular weight: Verify against predicted size (including any post-translational modifications)

• Protein isoforms: Check gene databases for alternative splicing variants

• Post-translational modifications: Consider phosphorylation, glycosylation, or farnesylation

• Degradation products: Test with different protease inhibitor cocktails

• Non-specific binding: Validate with blocking peptides and knockout controls

For S. pombe proteins specifically, post-translational modifications can dramatically affect migration patterns. For example, farnesylation of Rhb1 in S. pombe results in faster migration on SDS-PAGE, creating a characteristic doublet pattern in mutants with defective farnesylation .

What are the common pitfalls in immunofluorescence experiments with SPAC11D3.07c antibody and how can they be addressed?

Common immunofluorescence pitfalls when using SPAC11D3.07c antibody include:

• High background staining:

  • Cause: Insufficient blocking or antibody cross-reactivity

  • Solution: Optimize blocking buffer components (BSA, normal serum, Triton X-100 concentration)

• Weak or absent signal:

  • Cause: Inaccessible epitopes or overfixation

  • Solution: Test multiple fixation methods and permeabilization protocols

• Non-specific nuclear staining:

  • Cause: Electrostatic interactions with nucleic acids

  • Solution: Increase salt concentration in wash buffers, add nucleases to digestion steps

• Inconsistent staining patterns:

  • Cause: Variation in fixation/permeabilization efficiency

  • Solution: Standardize all steps of sample preparation

• Autofluorescence interference:

  • Cause: Cellular components or fixatives

  • Solution: Include appropriate quenching steps, utilize spectral unmixing

Research with antibodies against other S. pombe proteins demonstrates that the fixation method dramatically impacts the accessibility of intracellular antigens, with both fixation-only and membrane permeabilization protocols producing distinct results .

How can SPAC11D3.07c antibody be adapted for high-throughput or single-cell analysis techniques?

Adapting SPAC11D3.07c antibody for high-throughput and single-cell analyses requires specialized approaches:

• Microfluidic antibody arrays: For multiplexed protein detection from small samples

• Mass cytometry (CyTOF): Using metal-conjugated antibodies for high-dimensional single-cell profiling

• Single-cell Western blotting: For protein quantification at individual cell level

• In situ proximity ligation: For detecting protein interactions in individual cells

• Automated imaging platforms: For high-content screening with immunofluorescence

Implementation strategies include:

• Antibody conjugation with bright, photostable fluorophores

• Optimization for microfluidic platforms

• Validation using spike-in controls at single-cell concentrations

• Development of computational pipelines for complex data analysis

Research with other antibodies demonstrates the feasibility of high-throughput approaches. For example, high-throughput single-cell RNA and VDJ sequencing successfully identified 676 antigen-binding IgG1+ clonotypes in clinical studies .

What considerations should guide the selection of labeling strategies for SPAC11D3.07c antibody in advanced imaging applications?

For advanced imaging with SPAC11D3.07c antibody, consider these labeling strategy factors:

• Fluorophore selection criteria:

  • Brightness and photostability

  • Spectral compatibility with other probes

  • Size and potential impact on antibody binding

  • pH sensitivity in cellular compartments

• Direct vs. indirect detection trade-offs:

  • Direct labeling: Reduced background, simpler protocol

  • Indirect detection: Signal amplification, greater flexibility

• Novel labeling technologies:

  • Click chemistry for site-specific labeling

  • Quantum dots for improved brightness and stability

  • Nanobodies for improved penetration and resolution

• Super-resolution compatibility:

  • STORM-compatible dyes (e.g., Alexa 647)

  • STED-compatible fluorophores

  • Photoactivatable proteins for PALM

Recent studies demonstrate successful implementation of 111In-labeled antibodies for molecular imaging, showing that chelator selection significantly impacts radiochemical yield and purity .

How might computational antibody design approaches be applied to improve SPAC11D3.07c antibody specificity and performance?

Computational approaches to improve SPAC11D3.07c antibody include:

• Machine learning-based optimization:

  • Predict binding affinity changes from sequence modifications

  • Optimize paratope-epitope interactions

  • Reduce cross-reactivity through in silico screening

• Structure-guided engineering:

  • Use Alphafold2 predictions of SPAC11D3.07c structure

  • Model antibody-antigen complexes

  • Identify key binding residues for rational mutation

• High-performance computing applications:

  • Molecular dynamics simulations to predict binding stability

  • Free energy calculations to quantify binding improvements

  • Parallelized screening of large antibody variant libraries

• Integrated computational-experimental pipelines:

  • IsAb protocol implementation

  • Iterative design-test-learn cycles

  • Feedback loops between experimental data and computational predictions

These approaches mirror successful computational antibody design efforts that have utilized machine learning and supercomputing to evaluate nearly 90,000 mutant antibodies and perform over 175,000 in silico free energy calculations to optimize binding .